MedPath
HSA Approval

PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL

SIN15482P

PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL

PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL

May 11, 2018

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

J01CR05

piperacillin and beta-lactamase inhibitor

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Shandong Anxin Pharmaceutical Co., Ltd. (Workshop 2100)

Active Ingredients

Tazobactam sodium 0.537g eqv. Tazobactam

0.5g

Tazobactam

Piperacillin sodium 4.170g eqv. Piperacillin

4g

Piperacillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL - HSA Approval | MedPath